These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21392636)

  • 1. Atrial fibrillation: pharmacological therapy.
    Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR
    Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.
    de Denus S; Sanoski CA; Carlsson J; Opolski G; Spinler SA
    Arch Intern Med; 2005 Feb; 165(3):258-62. PubMed ID: 15710787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of persistent atrial fibrillation in the older adult: evidence-based practice.
    Stanley JM
    J Am Acad Nurse Pract; 2011 Mar; 23(3):120-6. PubMed ID: 21355944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is rate control better than rhythm control for atrial fibrillation in older high-risk patients?
    Saseen JJ
    J Fam Pract; 2003 Mar; 52(3):192, 194. PubMed ID: 12620170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.
    Waldo AL
    Am Heart J; 2006 Apr; 151(4):771-8. PubMed ID: 16569531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation.
    Andrews M; Nelson BP
    Mt Sinai J Med; 2006 Jan; 73(1):482-92. PubMed ID: 16470327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation.
    Kim MH
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):163-71. PubMed ID: 22390559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
    Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice.
    Dobrev D
    Expert Opin Pharmacother; 2011 Jun; 12(8):1195-1199. PubMed ID: 21548721
    [No Abstract]   [Full Text] [Related]  

  • 16. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to atrial fibrillation management: treat the patient, not the ECG.
    Pinter A; Dorian P
    Cardiovasc Ther; 2010 Oct; 28(5):302-10. PubMed ID: 20345495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidenced-based pharmacotherapy for rate control in atrial fibrillation.
    Greenberg H
    Crit Care Nurs Q; 2013; 36(2):237-43. PubMed ID: 23470710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.
    Sherman DG; Kim SG; Boop BS; Corley SD; Dimarco JP; Hart RG; Haywood LJ; Hoyte K; Kaufman ES; Kim MH; Nasco E; Waldo AL;
    Arch Intern Med; 2005 May; 165(10):1185-91. PubMed ID: 15911734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.